Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05898087 · ClinicalTrials.gov registry record · Phase 4
Subpectoral Bupivacaine for Pain Management in Adolescent Reduction Mammaplasty
A Phase 4 study of Post Operative Pain and Macromastia, sponsored by Connecticut Children's Medical Center.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 128
- Enrollment target
- 2
- Study locations
NCT05898087 is a Phase 4 study of Post Operative Pain and Macromastia that is actively recruiting participants, run by Connecticut Children's Medical Center. The registered enrollment target is 128 participants, below the 234-participant average among 56 other Post Operative Pain trials with a reported enrollment target (45% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT05898087, a Phase 4 study of Post Operative Pain and Macromastia, is actively recruiting participants, sponsored by Connecticut Children's Medical Center.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 128 participants
- Enrollment target
- 2
- Study locations
Study Summary
The main question this randomized control trial aims to answer is: • Is the use of intraoperative subpectoral bupivacaine associated with decreased post-operative pain in adolescent patients who undergo bilateral reduction mammaplasty Participants will be randomized into the study group that intraoperatively receives 30cc of subpectoral bupivacaine injections or into the control group that intraoperatively receives 30cc of injectable saline subpectorally. All participants will keep a pain log and pain medication log at home for the first week following surgery. Researchers will compare to see if patients who receive subpectoral bupivacaine have lower pain scores in the PACU, and lower use of narcotics post-operatively when compared to the control group who receive injectable saline.
Conditions Studied
Interventions
- DRUG Saline
- DRUG Marcaine 0.25 % Injectable Solution
Study Locations (2)
Connecticut
- Connecticut Children's - Farmington
- Connecticut Children's - Hartford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2022-04-01 |
| Est. Completion | 2026-04-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05898087
The ClinicalTrials.gov registry entry for NCT05898087 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 128 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 234-participant average among 56 other Post Operative Pain trials with a reported enrollment target (45% lower). The listed sponsor is Connecticut Children's Medical Center, which has 55 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Post Operative Pain appearing as the primary indexed condition, and to 2 interventions - of which Saline is the first listed.
NCT05898087 reports 2 study locations spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT05898087 about?
NCT05898087 is a clinical study titled "Subpectoral Bupivacaine for Pain Management in Adolescent Reduction Mammaplasty". The main question this randomized control trial aims to answer is: • Is the use of intraoperative subpectoral bupivacaine associated with decreased post-operative pain in adolescent patients who undergo bilateral reduction mammaplasty Participants will be randomized into the study group that intra...
What is the current status of trial NCT05898087?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 128 participants. The study started on 2022-04-01. Estimated completion is 2026-04-01.
What conditions does trial NCT05898087 study?
This clinical trial studies the following conditions: Post Operative Pain, Macromastia.
What interventions are being tested in trial NCT05898087?
The interventions under investigation include: Saline (DRUG), Marcaine 0.25 % Injectable Solution (DRUG).
Who is sponsoring clinical trial NCT05898087?
This trial is sponsored by Connecticut Children's Medical Center, which has 55 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05898087 being conducted?
This trial has 2 study locations across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post Operative Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study Of Corticosteroid On Postoperative Pain After Ureteroscopy For Urinary Calculi
RECRUITING · Phase 4
-
Preoperative Acetazolamide
RECRUITING · Phase 4
-
Methadone to Reduce Chronic Opioid Use After Major Spine Surgery: The MEND Pilot Feasibility Study
RECRUITING · Phase 4
-
Comparison of Interscalene Catheter to Single Injection Interscalene Blocks for Total Shoulder Arthroplasties
RECRUITING · Phase 4
-
Post Operative Infusion Pump Pain Study
RECRUITING · Phase 4
-
ZYNRELEF for Pain Management in Total Knee Arthroplasty
RECRUITING · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.